SOCIÉTÉ GÉNÉRALE, U.S. Medium-Term Note Program

The documents listed directly beneath the Offering Memorandum (the “Offering Memorandum”) are incorporated by reference into the Offering Memorandum, as in effect from time to time, relating to the U.S. medium term notes program of Société Générale.

OFFERING MEMORANDUM


	05/23/2022 SG Offering Memorandum dated May 23, 2022

SUPPLEMENTS TO THE OFFERING MEMORANDUM



	First Supplement to SG Offering Memorandum dated May 23, 2022

PRODUCT SUPPLEMENTS


	05/23/2022 Equity-Linked Notes Product Supplement

	05/23/2022 ETF-Linked Notes Product Supplement

	05/23/2022 Index-Linked Notes Product Supplement

	05/23/2022 Rate-Linked Notes Product Supplement

	05/23/2022 Credit-Linked Notes Product Supplement

	05/23/2022 Commodity-Linked Notes Product Supplement

	05/23/2022 Currency-Linked Notes Product Supplement

ANNUAL REPORT & QUARTERLY RESULTS OF SOCIETE GENERALE GROUP (THE "GROUP") AND UPDATES THERETO; PRESS RELEASES PUBLISHED UNDER REGULATED INFORMATION

ANNUAL REPORTS
	2023 Universal Registration Document

	3rd Amendment to 2022 Universal Registration Document

	2nd Amendment to 2022 Universal Registration Document

	1st Amendment to 2022 Universal Registration Document

	2022 Universal Registration Document

QUARTERLY RESULTS
	02/08/2023 Fourth Quarter 2022

	11/04/2022 Third Quarter 2022

	08/03/2022 Second Quarter 2022

	05/05/2022 First Quarter 2022

PRESS RELEASES
	Societe Generale Ceases Its Activities in Russia and Signs an Agreement to Sell Rosbank and Its Russian Insurance Subsidiaries

	Update on the Group's Current Situation in Ukraine and Russia

Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Offering Memorandum.

The Notes and the Guarantee described in the Offering Memorandum have not been, and will not be, registered under the Securities Act of 1933, as amended (the “Securities Act”) and, except as specified otherwise in the applicable Offering Memorandum Supplement, are being offered pursuant to the exemption from the registration requirements thereof contained in Section 3(a)(2) of the Securities Act.

The Notes and the Guarantee may also, in conjunction with or independently from the exemption from registration provided by Section 3(a)(2) of the Securities Act, be offered and sold (i) in the United States, only to persons who are “Accredited Investors” (as defined in Rule 501 of Regulation D, as amended, under the Securities Act) in reliance on Section 4(a)(2) of the Securities Act (the “Section 4(a)(2) Notes”), or (ii) in the United States, to “Qualified Institutional Buyers” (as defined in Rule 144A, as amended, under the Securities Act) in reliance on Rule 144A under the Securities Act (“Rule 144A Notes”) or (iii) outside the United States, in reliance on Regulation S under the Securities Act (“Regulation S Notes”). The Section 4(a)(2) Notes, Rule 144A Notes or Regulation S Notes, as applicable, have not been, and will not be, registered under the Securities Act, or the state securities laws of any state of the United States or the securities laws of any other jurisdiction. The Section 4(a)(2) Notes, Rule 144A Notes or Regulation S Notes, as applicable, may not be offered, sold, pledged or otherwise transferred except in a transaction exempt from, or not subject to, the registration requirements of the Securities Act. Prospective purchasers are hereby notified that (i) the seller of the Section 4(a)(2) Notes may be relying on the exemption from provisions of Section 5 of the Securities Act contained in Section 4(a)(2) thereof and (ii) the seller of Rule 144A Notes may be relying on the exemption from provisions of Section 5 of the Securities Act provided by Rule 144A. For a description of certain restrictions on transfers and resales of the Section 4(a)(2) Notes, Rule 144A Notes and Regulation S Notes, see the section entitled “Notice to Investors” in the Offering Memorandum.

The Issuer has not been registered under the Investment Company Act of 1940, as amended.

None of the Securities and Exchange Commission, any state securities commission or regulatory authority or any other United States, French or other regulatory authority has approved or disapproved of the Notes or the Guarantee or passed upon the accuracy or adequacy of the Offering Memorandum or any applicable Offering Memorandum Supplement. Any representation to the contrary is a criminal offense in the United States. Under no circumstances shall the Offering Memorandum and/or any applicable Offering Memorandum Supplement constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these Notes or the Guarantee, in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification under the securities laws of any such jurisdiction.

THE NOTES CONSTITUTE UNCONDITIONAL LIABILITIES OF THE ISSUER, AND THE GUARANTEE CONSTITUTES AN UNCONDITIONAL OBLIGATION OF THE GUARANTOR. THE NOTES AND THE GUARANTEE ARE NOT INSURED OR GUARANTEED BY THE FEDERAL DEPOSIT INSURANCE CORPORATION, THE BANK INSURANCE FUND OR ANY U.S. OR FRENCH GOVERNMENTAL OR DEPOSIT INSURANCE AGENCY.